Grants

Active Sponsored Projects

Naturally Occurring Canine Hemangiosarcoma as a Translational Model for Angiosarcoma

Sponsor: NIH/National Cancer Institute R01 (5 years; Jun 3, 2026 – ), PI

NIH RePORTER: https://reporter.nih.gov/search/ia5N9bhQ80SU2Mx_H3V0VQ/project-details/11343984

Development of AI-Driven Applications Supporting Pathologic Diagnosis, Treatment, and Prognosis Prediction for Three Major Canine Malignancies 

Sponsor: The Animal and Plant Quarantine Agency (3 years; Jan 1, 2026 – ), PI

Development of Subtype-Specific Preclinical Models for Translational Angiosarcoma

Sponsor: US Department of Defense (2 years; Aug 1, 2026 – ), Co-PI

Targeting TIE2 as a Novel Strategy in VEGFR Inhibitor-Resistant Angiosarcoma

Sponsor: US Department of Defense (2 years; Aug 1, 2025 – ), Co-PI

Agassiz’s Desert Tortoise (Gopherus agassizii) Genetic Analysis

Sponsor: Naval Facilities Engineering Systems Command Southwest (4 years; Sep 30, 2025 – ), Co-I

Dual Blockade of PI3K-Activating Mutations and Immune Signaling in Canine Hemangiosarcoma

Sponsor: Morris Animal Foundation (3 years, NCE; Mar 1, 2024 – ), PI

Establishment of Systemic Data Standardization for Artificial Intelligence-Implemented Veterinary Forensic Investigation and Animal Disease Diagnostics

Sponsor: The Animal and Plant Quarantine Agency (3 years; Jan 1, 2024 – ), PI

Are peptide signatures created using machine learning the future for early diagnosis of PPID? Development and Application of a Novel Diagnostic Test for PPID

Sponsor: Morris Animal Foundation (3 years; Sep 1, 2023 – ), Co-I

Completed at UF

Metabolic Liabilities and Hematopoietic Fate Decisions in PIK3CA/KDR Co-mutant Angiosarcoma

Sponsor: US Department of Defense (Sep 1, 2023 – Aug 31, 2025)

Chromatin Accessibility and the Convergent Oncogenic Pathways of Angiosarcomas

Sponsor: US Department of Defense (Apr 1, 2023 – Dec 31, 2024; transferred from previous institution)

Reprogramming the Tumor Immune Niche in Canine Hemangiosarcoma

Sponsor: AKC Canine Health Foundation (Oct 1, 2022 – Apr 30, 2023; transferred from previous institution)